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Background/aim: Sphingosine 1-phosphate receptor 2 (S1PR2), a member of the seven-transmembrane receptor family, can be
activated by its natural ligand sphingosine 1-phosphate (S1P) to initiate signal transduction and is involved in a wide range of biological
effects such as immune cell migration and vascular permeability. Its relationship with neuropathic pain (NP) has not been reported. In
this study, the effects of S1PR2 on the development of NP were studied.
Materials and methods: We generated a model of NP by partial sciatic nerve ligation (pSNL). The 50% paw withdrawal threshold of
the wild-type (WT) group and the S1PR2 deficiency group were measured at several time points after surgery. The inflammatory factor
levels of the two groups were measured by real-time quantitative polymerase chain reaction (RT-PCR). Neutrophil infiltration and glial
cell activation were detected by immunofluorescence. Matrix metalloproteinase 9 (MMP9) and its substrate myelin basic protein (MBP)
were measured by RT-PCR, western blotting, and immunofluorescence.
Result: The S1PR2 deficiency group showed a reduction in 50% paw withdrawal threshold compared with WT mice (P < 0.05) at 3 days
after the operation. In the ligated sciatic nerve of the S1PR2 deficiency group, the mRNA expression of IL-1β was increased; the numbers
of infiltrating neutrophils and activated astrocytes were also increased. The expression of MMP9 was elevated while MBP was decreased.
Conclusion: S1PR2 deficiency could increase the pain sensitivity of a NP mouse model and promote the development of NP.
Key words: Neuropathic pain, S1PR2, partial sciatic nerve ligation, matrix metalloproteinase

1. Introduction
Neuropathic pain (NP) is defined as ‘‘pain caused by a
lesion or disease of the somatosensory system’’, as stated by
the International Association for the Study of Pain in 2011
(1). The point prevalence of chronic pain with neuropathic
characteristics has been reported as 10.6% (95% CI: 9.75–
11.45) (2). NP causes substantial disability, but current
treatment is inadequate (3). Neuroimmune regulation
in the pathogenesis of NP has attracted attention, and
effective immune molecular targets for the treatment of
NP are currently being sought.
Sphingosine 1-phosphate receptor 2 (S1PR2), a
member of the seven-transmembrane (G-proteincoupled) receptor family, can be activated by its natural
ligand, sphingosine 1-phosphate (S1P), to initiate signal
transduction and is involved in a wide range of biological
effects (4). It has been shown that S1PR2 can modulate
immune cell migration (5) and vascular permeability (6)
and mediate changes in neuronal plasticity (7). It has also
been reported that immune cell infiltration (8), changes in

vascular permeability, and synaptic plasticity of neurons
can affect pain development (9,10). Therefore, the current
study was undertaken to explore the effect of S1PR2 on NP.
2. Materials and methods
2.1. Animals
All experiments were conducted in accordance with the
ethical guidelines of the animal care and use committee of
the relevant university (China). Adult C57BL/6 mice were
purchased from Shanghai SLAC Laboratory Animal Co.,
Ltd. (Shanghai, China). S1PR2-KO mice were obtained
from the Mutant Mouse Regional Resource Centers (USA;
MMRRC Strain ID, 12830). The mice were maintained
in a specific-pathogen-free mouse facility with food and
water ad libitum and were kept at a constant ambient
temperature of 24 ± 1 °C under a 12-h/12-h light/dark
cycle. The S1PR2-KO mouse line was backcrossed with
the C57BL/6 strain for at least seven generations, and
the heterozygous offspring were intercrossed to produce
wild-type (S1pr2+/+) and S1PR2-KO (S1pr2-/-) mice, which
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were used for the current investigation. Male mice aged
12–16 weeks were used in this study. All experiments were
performed on 12- to 16-week-old mice.
2.2. Pain models
All animals were housed in ventilated cages and were
acclimated for at least 1 week before any experimental
procedures. Both strains of mice were randomly divided
between two groups: left-side pSNL and sham surgery
only.
A pSNL mouse model was generated by unilateral
partial ligation of the sciatic nerve as described previously
with slight modifications (11). Briefly, all animals were
anesthetized with 1.5% to 2% isoflurane delivered via a
modified nose cone. Then a 5-mm incision was made to
expose the left sciatic nerve just distal to the branch leading
to the posterior biceps femoris/semitendinosus muscles.
The one-third to one-half diameter of the left sciatic nerve
at the upper thigh level was ligated tightly with an 8-0 silk
suture. Sham surgeries were also performed by exposing
the sciatic nerve without ligation. The wound was closed
by suturing the muscle and skin layers. The animals were
allowed to recover in their cages before further testing.
2.3. Behavioral test
Animals were acclimatized to the testing room for at least 1
h before behavioral tests. The same experimenter handled
and tested all animals in each experiment and was blinded
to the genotype and surgical treatment of each animal.
Mechanical sensitivity was assessed by the up-down
method using calibrated von Frey filaments as described
previously with slight modifications (12). Mice were
acclimatized on a metal mesh floor in small cylinders
(diameter 7.5 cm; height 10 cm) for 2 h. Mechanical
sensitivity was evaluated using a set of eight calibrated von
Frey filaments (0.008, 0.02, 0.04, 0.07, 0.16, 0.4, 0.6, 1.0,
and 1.4 g) that were applied to the plantar surface of the
hind paw until the filament bent slightly for a few seconds.
A withdrawal reflex of the hind paw during stimulation
or immediately after stimulus removal was considered
a positive response. The first stimulus was always the
0.16-g filament. When there was a positive response, the
next lower filament was applied, and when there was no
response, the next higher filament was used. After the
first change in response, four additional responses were
observed, and the 50% paw withdrawal threshold value
was calculated. When a positive response to a stimulus
with the 0.008-g filament or a negative response to a
stimulus with the 1.4-g filament was observed, values of
0.008 and 1.4 g were assigned, respectively.
2.4. RT-PCR
The injured sciatic nerve of pSNL-induced NP model mice
was cut 5 mm distal and proximal to the ligation site, and
the section was removed. Lumbar spinal cord samples

(L4–L6) were also harvested from the NP model mice.
Total RNA was extracted from the harvested tissues
(the injured sciatic nerve and the ipsilateral lumbar
enlargement at L4–L6) using TRIzol Reagent (Invitrogen,
Carlsbad, CA, USA). Complementary DNA was generated
by reverse transcription of 1 µg of total RNA using the
Reverse Transcription System (Promega, Madison, WI,
USA). Quantitative measurements of the S1PR2, IL1β, IL-6, TNF-α, MMP9, and MMP2 expression levels
were performed using the ABI 7500 Fast Real-Time
PCR system. A PCR volume of 20 µL contained 10 µL
of SYBR Premix Ex Taq II, 0.4 µL of ROX Reference Dye
II, 0.4 µL of each primer, and 0.4 µL of complementary
DNA. Each sample was assayed in triplicate. The reaction
conditions were as follows: heat activation for 10 min at
95 °C, followed by 40 cycles of 95 °C for 10 s, 60 °C for
30 s, and 72 °C for 30 s. The housekeeping gene β-actin
was used as an internal control. Gene expression levels
were determined using the 2–ΔΔCT relative quantification
method. The primer sequences are shown in the Table.
2.5. Western blot
The injured sciatic nerves were collected and
homogenized in RIPA lysis buffer containing a mixture of
PMSF and other protease inhibitors (Beyotime, Shanghai,
China). Protein samples were separated on a 12% BisTris polyacrylamide gel (Novex, USA) and transferred
onto polyvinylidene fluoride membranes (Millipore
Corporation, USA). The membranes were blocked
and then incubated overnight at 4 °C with a primary
antibody [rabbit anti-β-tubulin, 1:1000 (Santa Cruz,

Table. The primer sequences used in RT-PCR.
Primer

Sequences

β-actin

Forward: 5’-GTGACGTTGACATCCGTAAAGA-3’
Reverse: 5’-GCCGGACTCATCGTACTCC-3’

S1PR2

Forward: 5’-CACTGCTCAATCCTGTCA-3’
Reverse: 5’-GAAATGTCGGTGATGTAGG-3’

IL-1β

Forward: 5’-GAAATGCCACCTTTTGACAGTG-3’
Reverse: 5’-TGGATGCTCTCATCAGGACAG-3’

IL-6

Forward: 5’-GCCTTCTTGGGACTGATG-3’
Reverse: 5’-AGGTCTGTTGGGAGTGGTA-3’

TNF-α

Forward: 5’-TACTGAACTTCGGGGTGA-3’
Reverse: 5’-ACTTGGTGGTTTGCTACG-3’

MMP9

Forward: 5’-GGCTGTGGTCTTATCTCCAAC-3’
Reverse: 5’-TGATGTTATGATGGTCCCACTTG-3’

MMP2

Forward: 5’-CAAGTTCCCCGGCGATGTC-3’
Reverse: 5’-TTCTGGTCAAGGTCACCTGTC-3’
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Japan); rat antimyelin basic protein, 1:1000 (Abcam,
USA); rabbit anti-MMP9, 1:1000 (Abcam, USA)]. The
membranes were then incubated with the corresponding
HRP-conjugated secondary antibodies for 1 h at room
temperature before the blots were detected in ElectroChemi-Luminescence (ECL) solution (Pierce, USA) and
Kodak film (Carestream Health, Rochester, USA). The
developed films were scanned for data analysis.
2.6. Immunohistochemistry
Animals were anesthetized with 1.5% to 2% isoflurane
and perfused transcardially. Lumbar spinal cord samples
(L4–L6) and the injured sciatic nerve were removed.
Lumbar spinal cord samples were postfixed for 4 h, then
immersed in 30% sucrose dissolved in 0.01 M phosphate
buffer. Transverse spinal sections (20 µm) were cut in a
cryostat. Sections were blocked and then incubated with
primary antibodies [mouse anti-GFAP, Cy3 conjugate,
1:400 (Millipore, USA)] overnight at 4 °C. The injured
sciatic nerves were fixed in 4% paraformaldehyde for 3 to
6 h. Dehydrated, paraffin-embedded sections of 4 µm were
soaked in xylene and rehydrated before immunostaining.
Rehydrated samples were incubated at 95–100 °C for
10 min with sodium citrate buffer and then blocked,
incubated with primary antibodies [rat antimyelin basic
protein, 1:200 (Abcam, USA); rabbit anti-MMP9, 1:200
(Abcam, USA); mouse anti-β100, 1:300 (Abcam, USA);
rat anti-Ly6g, 1:100 (Abcam, USA); goat anti-IL-1β,
1:50 (R&D Systems, USA)]. All antibodies were diluted
in phosphate-buffered saline containing 5% fetal bovine
serum for 12–16 h at 4 °C. The corresponding secondary
antibodies [goat antirat conjugated to Alexa Fluor 488,
1:1000 (Invitrogen, USA); donkey antirabbit conjugated
to Cy3, 1:500 (Millipore, USA); goat antimouse
conjugated to FITC, 1:200 (Millipore, USA); donkey
antigoat conjugated to Alexa Fluor 488, 1:1000 (Abcam,
USA)] were incubated for 1 h at 4 °C in the dark. Then the
sections were covered with mounting medium containing
DAPI (Vector Laboratories, USA). Colocalization of
MMP9 with β100, Ly6g, or IL-1β was evaluated by
immunofluorescent staining. The images were captured
with a Leica fluorescence microscope. GFAP- and Ly6gpositive cells were counted using Image-Pro Plus 6.0.
2.7. Statistical analysis
Data are presented as means ± SEMs and were analyzed
using SPSS 16.0 or GraphPad Prism. The 50% withdrawal
thresholds were compared among the 4 groups or across
time points in one group using repeated-measures
ANOVA or one-way ANOVA, followed by a post hoc
LSD or Dunnett test, respectively. Differences between
two groups were compared using unpaired t-tests. In all
cases, differences of P < 0.05 were considered statistically
significant.
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3. Results
3.1. S1PR2 and pain-related gene expressions in a wildtype mouse model of neuropathic pain (Figures 1A–1H)
After partial ligation of the sciatic nerve, the 50%
withdrawal thresholds on day 3, day 7, and day 14 after
surgery showed significant differences from the baseline
(P < 0.05) (Figure 1A). Pain-related gene expressions
such as IL-1β, IL-6, TNF-α, MMP2, and MMP9 were
increased after surgery (Figures 1D–1H). The reduced
pain threshold and elevated pain-related gene expressions
meant that the NP model had been generated successfully.
Then S1PR2 expression was measured in the ipsilateral
lumbar spinal cord and the injured sciatic nerve. In L4–L6,
there was no difference in S1PR2 mRNA expression after
surgery compared with the baseline (Figure 1C). However,
in the ligated sciatic nerve, the S1PR2 mRNA expression
after surgery was markedly decreased compared with the
baseline (P < 0.05) (Figure 1B). These results showed that
S1PR2 mRNA might be involved in the development of
NP.
3.2. Neutrophil infiltration in injured nerves and astrocyte activation in lumbar spinal cord in a wild-type
mouse model of neuropathic pain
After partial ligation of the sciatic nerve in a wild-type
mouse, Ly6g-positive cells (neutrophils) were observed
near the injury site of the sciatic nerve at day 3 after pSNL
(Figure 2). At the same time, the astrocytes (GFAP-positive
cells) began to be activated in the ipsilateral dorsal horn
(Figure 3). Consistent with previously reported studies
(12,13), these results reconfirmed that the NP model had
been generated successfully.
3.3. S1PR2-deficient neuropathic pain model mice show
a decreased mechanical threshold
To assess whether S1PR2 deficiency alters physiological
pain, we compared the nocifensive responses of WT
and S1PR2-KO mice (produced by the heterozygous
offspring intercrossing) to mechanical stimuli. In the von
Frey filament test, there was no difference in the 50%
withdrawal threshold of the hind paw upon mechanical
stimulation between WT and S1PR2-KO mice (Figure
4A). Since there was no difference in pain under normal
physiological conditions, we observed the mechanical
threshold change after surgery. Figure 4B shows that
after pSNL, the mechanical thresholds of the two surgery
groups declined obviously (P < 0.05), while the mechanical
thresholds of the two sham groups did not alter obviously
compared with the baseline. When comparing each group
at each time point, we found that at day 3 after surgery,
the mechanical threshold of the S1PR2-KO group was
significantly lower than those of the other 3 groups (P <
0.05). These results implied that S1PR2 could affect NP
induced by pSNL.
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Figure 1. S1PR2 and pain-related genes expression in pSNL-induced NP mice. A) In WT NP mice, 50% withdrawal thresholds to
mechanical stimuli were assessed (n = 6). *P < 0.05 vs. baseline value. B, C) S1PR2 expression in the wild-type NP model mice. S1PR2
mRNA expression was tested by RT-PCR in both the ligated sciatic nerve (B) and the ipsilateral lumbar spinal cord (L4–L6) (C) (n =
5–6). *P < 0.05 vs. baseline value. D–H) Pain-related gene expressions of IL-1β, IL-6, TNF-α, MMP2, and MMP9 in the ligated sciatic
nerve, respectively (n = 5–6). *P < 0.05 vs. baseline value. n.s., Not significant.

3.4. Lack of influence of S1PR2 on cytokine and matrix
metalloproteinase production in the damaged nerves
Since depletion of S1PR2 resulted in the mechanical
threshold decreasing at day 3 after surgery, we
mainly focused on this time point to measure related
proinflammatory cytokines and matrix metalloproteinases
that are known, based on previous reports, to be present
in increased amounts after pSNL (8,12–14). Thus, the
mRNA levels of TNF-α, IL-6, IL-1β, MMP9, and MMP2
in the different groups of mice were examined using RTPCR (Figures 5A–5E). Our results showed that IL-1β
expression was significantly higher in S1PR2-KO mice
than in WT mice. The other 2 cytokines presented no
difference. MMP9 expression in S1PR2-KO mice was also
significantly higher than that in WT mice. In addition,

the results of a western blot for MMP9 yielded similar
results (Figure 5F). These data implied that the change in
mechanical sensitivity might be mediated by the elevation
of IL-1β and MMP9 expression.
3.5. S1PR2 deficiency and neutrophil infiltration in injured nerves and astrocyte activation in lumbar spinal
cord after partial sciatic nerve ligation
To assess whether S1PR2 modulates inflammatory responses
in a NP model, we carried out immunohistochemistry
staining for different immune cells both in the peripheral
ligated nerve and in the central lumbar spinal cord (L4–
L6). An accumulation of Ly6g-positive cells was observed
near the ligation site of the sciatic nerve at day 3 after
pSNL. The number of positive cells was greater in S1PR2KO mice than in WT mice (Figures 6A–6C). The number
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Figure 2. Neutrophil infiltration in the sciatic nerve in a wild-type mouse model. A, D) Ly6g-positive cells. B, E) DAPI, which marked
the nucleic acids. C, F) Double immunofluorescence merged from the two pictures on the left. Red circles represent neutrophils. P0
means baseline. P3 means 3 days after pSNL. Scale bars: 50 µm.

of activated astrocytes was greater in the ipsilateral dorsal
horn of S1PR2-KO mice than in that of WT mice. However,
there was no difference in the ipsilateral ventral horn.
Furthermore, we found that astrocytes from S1PR2-KO
mice developed thicker cell bodies and larger processes
(Figures 6D–6H). This revealed that S1PR2 depletion
could lead to more neutrophil infiltration and astrocyte
activation.
3.6. Location of matrix metalloproteinase 9 in the peripheral sciatic nerve after surgery
Schwann cells can produce MMP9, which modulates
neuroinflammation, in response to nerve crush injury (14).
Neutrophils can participate in the tissue’s inflammatory
reaction by releasing MMP9 in the ischemic brain after
occlusion/reperfusion (15). Since the MMP9 expression
of S1PR2-KO mice was increased significantly at day 3
after surgery, we examined the localization of MMP9
by immunofluorescence. We found that the neutrophil
marker Ly6g colocalized with MMP9 (Figure 7A), and
the colocalization between MMP9 and the Schwann cell
marker β-S100 was not obvious (Figure 7B). A previous
report suggested that MMP9 could cleave IL-1β precursors
to produce the mature form (16). In this study, we found
that MMP9 and IL-1β were clearly colocalized (Figure
7C). These results implied that S1PR2 deficiency could
lead to more neutrophil infiltration and MMP9 release,
after which MMP9 would cleave IL-1β precursors into
mature IL-1β.
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3.7. Lack of influence of S1PR2 on myelin basic protein
expression in the peripheral sciatic nerve
MMP9 plays a critical role in demyelination in the central
and peripheral nervous systems (14,17). It can degrade
myelin basic protein (MBP) synthesized by Schwann
cells, which is critical for maintaining the integrity of
the peripheral nerves (18–20). Therefore, we detected
MBP expression in the injured sciatic nerve at day 3 after
surgery. The MBP abundance in S1PR2-KO mice was
significantly lower than that in WT mice. In addition,
the immunofluorescence images showed consistent
results (Figures 7D–7G). These data suggested that S1PR2
deficiency could cause an increase in MMP9 expression
followed by more degradation of MBP.
4. Discussion
In this study, we first observed the relationship between
the dynamic change in S1PR2 mRNA and the change in
the pain threshold of WT mice with NP. As expected,
S1PR2 mRNA expression in the injured nerve decreased
after pSNL. Next, S1PR2-KO mice were used to study the
role of S1PR2 in the formation of NP. The result showed
that S1PR2 deficiency could reduce the mechanical
threshold at day 3 after surgery compared with WT mice.
Then we focused on this time point to seek the underlying
cellular and molecular mechanisms. For S1PR2-KO
mice, the number of activated astrocytes whose bodies
became thicker and processes grew larger was increased
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Figure 3. Astrocyte activation in lumbar spinal cord in a wild-type mouse model. Sections in the ipsilateral lumbar spinal cord were
immunostained with an activated astrocyte marker (GFAP antibody, red). White boxes represent the ipsilateral dorsal horn. A and B
are magnified by a factor of 40×. C and D are magnified by a factor of 100×. P0 means baseline. P3 means 3 days after pSNL. Ips means
ipsilateral.

Figure 4. S1PR2 deficiency leading to a change in mechanical sensitivity. A) The physiological pain thresholds of WT and S1PR2-KO
mice (n = 12). n.s., Not significant. B) The changes in 50% withdrawal threshold after surgery. *P < 0.05 between the S1PR2-KO surgery
group and each of the other 3 groups. #P < 0.05 between each of the 2 surgery groups and their corresponding sham group. ○ P < 0.05
between the nerve-ligated group of S1PR2-KO mice and its own baseline value. ● P < 0.05 between the nerve-ligated group of WT mice
and its own baseline value. Data are expressed as means ± SEMs. n = 5–6.
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Figure 5. The expression of cytokines and matrix metalloproteinases in the damaged sciatic nerves at 3 days after surgery. A–E) mRNA
expression of IL-1β, IL-6, TNF-α, MMP2, and MMP9, respectively. F) Representative western blot comparing the protein expression of
MMP9 between 2 groups. *P < 0.05 between the WT group and the S1PR2-KO group. n.s., Not significant. Data are expressed as means
± SEM. n = 5–6.

Figure 6. Neutrophil infiltration into injured sciatic nerves and astrocyte activation in the lumbar spinal cord after pSNL. A, B) Sections
around the pSNL ligation site of WT and S1PR2-KO mice were immunostained with a neutrophil marker (Ly6g antibody, green) and
a nucleic acid dye (DAPI, blue). Red circles represent neutrophils. The images are magnified by a factor of 400×. C) The number of
Ly6g-positive cells in the sections were counted. D) The GFAP-positive cells in the sections were counted. E, H) The ipsilateral dorsal
horn is shown, magnified by a factor of 400×. F, G) Sections in the ipsilateral lumbar spinal cord were immunostained with an activated
astrocyte marker (GFAP antibody, red). White boxes represent the ipsilateral dorsal and ventral horn, where the cells were counted. The
images are magnified by a factor of 200×. *P < 0.05. n.s., Not significant. Data are expressed as means ± SEM. n = 5.
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Figure 7. Localization of matrix metalloproteinase 9 in the peripheral sciatic nerve and expression of its substrate MBP. A–C) Green
represents Ly6g, β-S100, and IL-1β. Red marks MMP9 and blue marks DAPI. The right-most picture shows triple immunofluorescence
merged from the three pictures on the left. Scale bars: 25 µm. D, E) Sections of the injured sciatic nerves of WT and S1PR2-KO mice 3
days after pSNL were double immunofluorescence stained for MBP (green) and nucleic acids (DAPI, blue). The images are magnified
by a factor of 400×. F, G) Representative comparison of MBP expression between the two groups by western blot. *P < 0.05. Data are
expressed as means ± SEM. n = 4.

in the central lumbar spinal cord; the number of infiltrated
neutrophils was also increased in the peripheral ligated
sciatic nerve. Next, proinflammatory cytokines and matrix
metalloproteinases were measured. IL-1β and MMP9
expression levels were higher in the S1PR2-KO group than
in the WT group. Since it has been reported that MMP9 can
cleave the IL-1β precursor into the mature form (16), we
observed the localization of MMP9 and its colocalization
with IL-1β. Finally, the expression of MMP9’s substrate
MBP was checked.
IL-1β is a highly proinflammatory cytokine that is
produced as a result of inflammasome assembly, which

activates the cysteine protease caspase-1. Caspase-1, in
turn, cleaves the IL-1β precursor into the active form (21–
24). Unpublished data from our group demonstrated that
S1PR2 in macrophages under inflammatory stimulation
causes inflammasome assembly and the production of
active IL-1β. When S1PR2 is knocked out, the expression
of active IL-1β declines. However, in this study, the
depletion of S1PR2 led to elevated expression of IL-1β,
which implied that the increase of IL-1β may not be due to
the S1PR2-KO macrophages.
In addition to being cleaved by caspase-1, the precursor
of IL-1β can also be cleaved by MMP9 and MMP2
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(16). MMP9 and MMP2 belong to the family of matrix
metalloproteinases, which are zinc ion- and calciumdependent enzymes and have the ability to degrade the
extracellular matrix (25). Increased expression of MMP9
and MMP2 was induced by peripheral nerve injury, which
can destroy the basal lamina around the capillary, leading to
the collapse of the vascular nerve barrier and the subsequent
recruitment of more neutrophils from the blood (26). In
the present study, the finding that MMP9 is elevated in
S1PR2-KO mice is not in conflict with the increased IL-1β
expression. MBP is the major structural protein of myelin,
which mediates intracellular signal transduction through
its interaction with actin and tubulin (27).
Because S1PR2 is widely expressed in the pain
conduction pathway, we were unable to characterize the
full spatial expression pattern of S1PR2, which will need

to be confirmed in further experiments. Furthermore, the
mechanisms of the increase in MMP9 expression after
S1PR2 knockdown and its interaction with IL-1β are not
well understood and will need further study in the future.
In conclusion, our results first indicate that S1PR2
deficiency in mice with NP could result in a decreased
mechanical pain threshold through accumulated
neutrophil infiltration and activated astrocytes, as well as
elevated IL-1β/MMP9 production at the site of the nerve
injury. S1PR2 may be a promising target for the treatment
of NP.
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